These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27550933)

  • 1. Polysaccharide Capsule Composition of Pneumococcal Serotype 19A Subtypes Is Unaltered among Subtypes and Independent of the Nutritional Environment.
    Brugger SD; Troxler LJ; Rüfenacht S; Frey PM; Morand B; Geyer R; Mühlemann K; Höck S; Thormann W; Furrer J; Christen S; Hilty M
    Infect Immun; 2016 Nov; 84(11):3152-3160. PubMed ID: 27550933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.
    Kaplan SL; Barson WJ; Lin PL; Stovall SH; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Mason EO
    Pediatrics; 2010 Mar; 125(3):429-36. PubMed ID: 20176669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.
    Pai R; Moore MR; Pilishvili T; Gertz RE; Whitney CG; Beall B;
    J Infect Dis; 2005 Dec; 192(11):1988-95. PubMed ID: 16267772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole Genome Sequencing of 39 Invasive Streptococcus pneumoniae Sequence Type 199 Isolates Revealed Switches from Serotype 19A to 15B.
    Makarewicz O; Lucas M; Brandt C; Herrmann L; Albersmeier A; Rückert C; Blom J; Goesmann A; van der Linden M; Kalinowski J; Pletz MW
    PLoS One; 2017; 12(1):e0169370. PubMed ID: 28046133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013.
    Cho EY; Choi EH; Kang JH; Kim KH; Kim DS; Kim YJ; Ahn YM; Eun BW; Oh SH; Cha SH; Cho HK; Hong YJ; Kim KN; Kim NH; Kim YK; Kim JH; Lee H; Lee T; Kim HM; Lee KS; Kim CS; Park SE; Kim YM; Oh CE; Ma SH; Jo DS; Choi YY; Lee J; Bae GR; Park O; Park YJ; Kim ES; Lee HJ
    J Korean Med Sci; 2016 Jul; 31(7):1082-8. PubMed ID: 27366006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
    Moore MR; Gertz RE; Woodbury RL; Barkocy-Gallagher GA; Schaffner W; Lexau C; Gershman K; Reingold A; Farley M; Harrison LH; Hadler JL; Bennett NM; Thomas AR; McGee L; Pilishvili T; Brueggemann AB; Whitney CG; Jorgensen JH; Beall B
    J Infect Dis; 2008 Apr; 197(7):1016-27. PubMed ID: 18419539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence diversity within the capsular genes of Streptococcus pneumoniae serogroup 6 and 19.
    Elberse K; Witteveen S; van der Heide H; van de Pol I; Schot C; van der Ende A; Berbers G; Schouls L
    PLoS One; 2011; 6(9):e25018. PubMed ID: 21949837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine.
    Suga S; Chang B; Asada K; Akeda H; Nishi J; Okada K; Wakiguchi H; Maeda A; Oda M; Ishiwada N; Saitoh A; Oishi T; Hosoya M; Togashi T; Oishi K; Ihara T
    Vaccine; 2015 Nov; 33(45):6054-60. PubMed ID: 26235372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolated from invasive infections after optional use of the 7-valent conjugate vaccine in Korea, 2006-2010.
    Cho EY; Lee H; Choi EH; Kim YJ; Eun BW; Cho YK; Kim YK; Jo DS; Lee HS; Lee J; Kim MN; Kim DS; Lee HJ
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):481-6. PubMed ID: 24529940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the Seven-valent Pneumococcal Conjugate Vaccine on Acute Otitis Media in Japanese Children: Emergence of Serotype 15A Multidrug-resistant Streptococcus pneumoniae in Middle Ear Fluid Isolates.
    Ozawa D; Yano H; Endo S; Hidaka H; Kakuta R; Okitsu N; Kanamori H; Ogawa M; Ichimura S; Shimojima M; Inomata S; Kaku M; Katori Y
    Pediatr Infect Dis J; 2015 Sep; 34(9):e217-21. PubMed ID: 26083590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pneumococcal Serotype 15C Capsule Is Partially O-Acetylated and Allows for Limited Evasion of 23-Valent Pneumococcal Polysaccharide Vaccine-Elicited Anti-Serotype 15B Antibodies.
    Spencer BL; Shenoy AT; Orihuela CJ; Nahm MH
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
    Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
    Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development.
    Reinert R; Jacobs MR; Kaplan SL
    Vaccine; 2010 Jun; 28(26):4249-59. PubMed ID: 20416266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal Mastoiditis in Children Before and After the Introduction of Conjugate Pneumococcal Vaccines.
    Koutouzis EI; Michos A; Koutouzi FI; Chatzichristou P; Parpounas K; Georgaki A; Theodoridou M; Tsakris A; Syriopoulou VP
    Pediatr Infect Dis J; 2016 Mar; 35(3):292-6. PubMed ID: 26569193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae.
    Park IH; Pritchard DG; Cartee R; Brandao A; Brandileone MC; Nahm MH
    J Clin Microbiol; 2007 Apr; 45(4):1225-33. PubMed ID: 17267625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 13-valent pneumococcal conjugate vaccine (PCV13).
    Jefferies JM; Macdonald E; Faust SN; Clarke SC
    Hum Vaccin; 2011 Oct; 7(10):1012-8. PubMed ID: 21941097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.